Your browser doesn't support javascript.
loading
Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization.
King, Sontoria D; Veliginti, Swathi; Brouwers, Martijn C G J; Ren, Zhewen; Zheng, Wei; Setiawan, Veronica W; Wilkens, Lynne R; Shu, Xiao-Ou; Arslan, Alan A; Beane Freeman, Laura E; Bracci, Paige M; Canzian, Federico; Du, Mengmeng; Gallinger, Steven J; Giles, Graham G; Goodman, Phyllis J; Haiman, Christopher A; Kogevinas, Manolis; Kooperberg, Charles; LeMarchand, Loic; Neale, Rachel E; Visvanathan, Kala; White, Emily; Albanes, Demetrius; Andreotti, Gabriella; Babic, Ana; Berndt, Sonja I; Brais, Lauren K; Brennan, Paul; Buring, Julie E; Rabe, Kari G; Bamlet, William R; Chanock, Stephen J; Fuchs, Charles S; Gaziano, J Michael; Giovannucci, Edward L; Hackert, Thilo; Hassan, Manal M; Katzke, Verena; Kurtz, Robert C; Lee, I-Min; Malats, Núria; Murphy, Neil; Oberg, Ann L; Orlow, Irene; Porta, Miquel; Real, Francisco X; Rothman, Nathaniel; Sesso, Howard D; Silverman, Debra T.
Afiliação
  • King SD; Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Jacksonville, Florida.
  • Veliginti S; Division of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic, Jacksonville, Florida.
  • Brouwers MCGJ; Division of Endocrinology and Metabolic Diseases, Department of Internal Medicine, Maastricht University Medical Center, Maastricht, the Netherlands.
  • Ren Z; CARIM School for Cardiovascular Diseases, Maastricht University, Maastricht, the Netherlands.
  • Zheng W; Division of Endocrinology and Metabolic Diseases, Department of Internal Medicine, Maastricht University Medical Center, Maastricht, the Netherlands.
  • Setiawan VW; CARIM School for Cardiovascular Diseases, Maastricht University, Maastricht, the Netherlands.
  • Wilkens LR; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee.
  • Shu XO; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California.
  • Arslan AA; Cancer Epidemiology Division, Population Sciences in the Pacific Program, University of Hawaii Cancer Center, University of Hawaii at Manoa, Honolulu, Hawaii.
  • Beane Freeman LE; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee.
  • Bracci PM; Departments of Obstetrics and Gynecology, Population Health and Environmental Medicine, NYU Perlmutter Comprehensive Cancer Center, New York, New York.
  • Canzian F; Division of Cancer Epidemiology and Genetics, NCI, NIH, Bethesda, Maryland.
  • Du M; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California.
  • Gallinger SJ; Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Giles GG; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Goodman PJ; Hepatobiliary/Pancreatic Surgical Oncology Program, University Health Network, Toronto, Ontario, Canada.
  • Haiman CA; The Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
  • Kogevinas M; Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Victoria, Australia.
  • Kooperberg C; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Victoria, Australia.
  • LeMarchand L; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
  • Neale RE; SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Visvanathan K; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California.
  • White E; Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain.
  • Albanes D; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Andreotti G; Cancer Epidemiology Division, Population Sciences in the Pacific Program, University of Hawaii Cancer Center, University of Hawaii at Manoa, Honolulu, Hawaii.
  • Babic A; Cancer Epidemiology Division, Population Sciences in the Pacific Program, University of Hawaii Cancer Center, University of Hawaii at Manoa, Honolulu, Hawaii.
  • Berndt SI; Population Health Program, QIMR Berghofer Medical Research Institute, Brisbane, Australia.
  • Brais LK; Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, Maryland.
  • Brennan P; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, Maryland.
  • Buring JE; Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Rabe KG; Division of Cancer Epidemiology and Genetics, NCI, NIH, Bethesda, Maryland.
  • Bamlet WR; Division of Cancer Epidemiology and Genetics, NCI, NIH, Bethesda, Maryland.
  • Chanock SJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Fuchs CS; Division of Cancer Epidemiology and Genetics, NCI, NIH, Bethesda, Maryland.
  • Gaziano JM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Giovannucci EL; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
  • Hackert T; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Hassan MM; Division of Preventive Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
  • Katzke V; Department of Quantitative Health Sciences, Mayo Clinic College of Medicine, Rochester, Minnesota.
  • Kurtz RC; Department of Quantitative Health Sciences, Mayo Clinic College of Medicine, Rochester, Minnesota.
  • Lee IM; Division of Cancer Epidemiology and Genetics, NCI, NIH, Bethesda, Maryland.
  • Malats N; Yale Cancer Center, New Haven, Connecticut.
  • Murphy N; Department of Medicine, Yale School of Medicine, New Haven, Connecticut.
  • Oberg AL; Smilow Cancer Hospital, New Haven, Connecticut.
  • Orlow I; Division of Preventive Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
  • Porta M; Boston Veteran Affairs Healthcare System, Boston, Massachusetts.
  • Real FX; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Rothman N; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Sesso HD; Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Silverman DT; Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany.
Cancer Epidemiol Biomarkers Prev ; 32(9): 1265-1269, 2023 09 01.
Article em En | MEDLINE | ID: mdl-37351909
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Hepatopatia Gordurosa não Alcoólica Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cancer Epidemiol Biomarkers Prev Assunto da revista: BIOQUIMICA / EPIDEMIOLOGIA / NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Hepatopatia Gordurosa não Alcoólica Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cancer Epidemiol Biomarkers Prev Assunto da revista: BIOQUIMICA / EPIDEMIOLOGIA / NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article